| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/20/2026 | ±2.3% | -6.8% | under-priced |
| 07/21/2026 | ±2.1% | +4.9% | under-priced |
| 04/28/2026 | ±2.3% | +1.3% | over-priced |
| 01/27/2026 | ±3.0% | +8.8% | under-priced |
| 10/21/2025 | ±2.9% | +14.9% | under-priced |
| 07/22/2025 | ±1.8% | -8.1% | under-priced |
| 05/01/2025 | ±3.4% | -0.4% | over-priced |
| 01/28/2025 | ±3.0% | -8.9% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.73 | $50.0B | $3.3B |
| Q2 FY2026 | $1.41 | $48.0B | $1.3B |
| Q1 FY2026 | $2.82 | $43.6B | $2.6B |
| Q4 FY2025 | — | $45.3B | $-3.3B |
GM (GM) reports in 84 days, with the next report estimated for 01/19/2027. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 6.8% on average — the market has tended to under-price GM's earnings risk. Fundamentals into the print: EPS up 176.3% year-over-year, revenue up 2.9%. QuantLogix's live 5-factor engine currently reads GM as a neutral at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →